Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Enzo Life Sciences Launches New PLAQPRO™ Lp-PLA2 Assay to Measure Cardiac Risk

Enzo Life Sciences is proud to introduce our new assay, PLAQPRO™ Lp-PLA2 Assay, measuring the activity of Lp-PLA2 in vitro. Lp-PLA2 is produced by inflammatory cells and circulates primarily bound to LDL. The oxidization of LDL is an early key event in the pathogenesis of atherosclerosis. Increased levels of Lp-PLA2 have been found in atherosclerotic plaques and rupture lesions.

The PLAQPRO™ Lp-PLA2 Assay is a colorimetric readout assay that measures the activity of Lp-PLA2 in serum samples. Our assay represents a cost-efficient alternative to the competitor’s Lp-PLA2 detection system, and is designed to run on automated chemistry analyzers. Included in the kit are ready-to-use calibration standards and QC controls in order to measure a wide analytical range of 0.0 – 400.0 nmol/min/mL of Lp-PLA2 activity.

PLAQPRO™ Lp-PLA2 Assay is the latest in Enzo’s line of cost-effective, highly adaptable, and high performance products and kits. This assay represents another addition to Enzo’s considerable portfolio of cardiovascular products, including Troponin I, CRP, Cytokine, and Adiponectin ELISAs, our Cardiotoxicity Library, and many proteins and antibodies to detect and measure vasodilation and vasoconstriction.

About Enzo Life Sciences

Enzo Life Sciences, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York. Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and therapeutics through the development of unique diagnostic platform technologies. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products and services that meet the ever-changing and rapidly growing needs of healthcare. Underpinning Enzo Biochem’s technologies, platforms and products is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.

Enzo Life Sciences, Inc. is a pioneer in labeling and detection technologies from genome to whole cell across research and diagnostic markets. We are focused on providing cost-effective, relevant and reliable solutions for life science research, drug development, and clinical research. We are organized to lead in the development, production, marketing, and sales of innovative research tools worldwide based on 40 years’ experience in building strong global market recognition and implementing outstanding operational capabilities.

New Product Release
Date: November 2nd 2016

For additional Information, please contact:
Kara Cannon, Global Head of Marketing
1-631-694-7070 x 1301

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,